Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Infect Dev Ctries ; 18(4): 501-503, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38728635

ABSTRACT

We proposed that the pharynx, as a common organ of the respiratory and digestive tracts, may be a respiratory and digestive tract cross cryptic transmission pathway for 2019-nCoV infection from the nasal cavities to the pharynx and lung, then to nasal cavities by aerosol (respiratory route) to the pharynx and the gastrointestinal tract, then to the oral cavity by feces (fecal-oral route) and to pharynx, lungs, or gastrointestinal tract.


Subject(s)
COVID-19 , Pharynx , SARS-CoV-2 , Humans , COVID-19/transmission , Pharynx/virology , Cross Infection/transmission , Gastrointestinal Tract/virology , Feces/virology , Feces/microbiology , Respiratory Tract Infections/transmission , Respiratory Tract Infections/virology
2.
PLoS One ; 15(9): e0239532, 2020.
Article in English | MEDLINE | ID: mdl-32976531

ABSTRACT

To investigate the clinical value of changes in the subtypes of peripheral blood lymphocytes and levels of inflammatory cytokines in patients with COVID-19, the total numbers of lymphocytes and CD4+ lymphocytes and the ratio of CD4+/CD8+ lymphocytes were calculated and observed in different groups of patients with COVID-19. The results show that the lymphocytopenia in patients with COVID-19 was mainly manifested by decreases in the CD4+ T lymphocyte number and the CD4+/CD8+ ratio. The decreased number of CD4+ T lymphocytes and the elevated levels of TNF-α and IL-6 were correlated with the severity of COVID-19 disease.


Subject(s)
CD4-Positive T-Lymphocytes/pathology , Coronavirus Infections/blood , Coronavirus Infections/immunology , Cytokines/blood , Pneumonia, Viral/blood , Pneumonia, Viral/immunology , Adolescent , Adult , Aged , Betacoronavirus , CD4 Lymphocyte Count , CD4-CD8 Ratio , COVID-19 , Child , Coronavirus Infections/diagnosis , Female , Humans , Interleukin-6/blood , Lymphopenia/blood , Lymphopenia/pathology , Male , Middle Aged , Pandemics , Pneumonia, Viral/diagnosis , SARS-CoV-2 , Severity of Illness Index , Tumor Necrosis Factor-alpha/blood
3.
J Med Chem ; 62(20): 9299-9314, 2019 10 24.
Article in English | MEDLINE | ID: mdl-31556611

ABSTRACT

In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory effect by dual luciferase-reporter assay. Based on five rounds of investigation on structure-activity relationships step by step, compound 30m was discovered as the most active inhibitor (IC50 = 0.32 µM) with no obvious cytotoxicity (CC50 > 50 µM). It effectively attenuated hypoxia-induced HIF-1α protein accumulation and reduced transcription of vascular epidermal growth factor in a dose-dependent manner, which was further demonstrated by its inhibitory potency on capillary-like tube formation, angiogenesis of zebrafish as well as cellular migration and invasion. Importantly, compound 30m exhibited antimetastatic potency in breast cancer lung metastasis in the mice model, indicating its promising therapeutic potential for prevention and treatment of tumor metastasis. These results definitely merit attention for further rational design of more efficient HIF-1 inhibitors in the future.


Subject(s)
Amides/chemistry , Antineoplastic Agents/chemistry , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Amides/metabolism , Amides/pharmacology , Amides/therapeutic use , Animals , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Movement/drug effects , Cell Survival/drug effects , Drug Design , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors , Inhibitory Concentration 50 , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Mice , Mice, Nude , Neovascularization, Physiologic/drug effects , Signal Transduction/drug effects , Structure-Activity Relationship , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/metabolism , Zebrafish/physiology
4.
Am J Emerg Med ; 36(2): 202-207, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28780983

ABSTRACT

BACKGROUND: Insulin, as an anti-inflammatory drug, could not be freely used in patients who experienced trauma according to the degree of inflammation, because of the side effect of hypoglycemia. In vivo experimental evidence is lacking concerning whether the effect is dosage dependent and whether it relies on controlling hyperglycemia. METHODS: By adjusting the dosage ratio of glucose and insulin, different dosages of insulin were used to treat severely scalded MODS rats to achieve uncontrolled or controlled hyperglycemia. One hundred forty rats with severe scalded were randomly divided into a hyperglycemia-controlled group, hyperglycemia-uncontrolled group, and control group. The levels of inflammation response indexes and major organ dysfunction indexes were measured and compared between groups. RESULTS: The blood indexes of inflammatory response and major organ dysfunction did not show statistical difference between hyperglycemia-controlled groups (A) and uncontrolled groups (B) in the same dosage of insulin (all P>0.05). The blood indexes of inflammatory response and major organ dysfunction demonstrated statistical difference in different dosages of insulin with hyperglycemia-controlled groups (A1-A3 groups) and hyperglycemia-uncontrolled groups (B1-B3 groups) (all P<0.01). The higher dosage of insulin, the better effect of anti-inflammation and organ protection it would demonstrate with or without controlling hyperglycemia. CONCLUSIONS: The effect of anti-inflammation and organ protection of insulin is dosage dependent in vivo; it does not rely on controlling hyperglycemia. Temporary traumatic hyperglycemia itself might not be detrimental to the body. Adjusting the ratio of insulin and glucose could provide a novel train of thought for freely treating patients with severe traumatic injury with different dosages of insulin according to the degree of inflammation.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Burns/drug therapy , Insulin/pharmacology , Protective Agents/pharmacology , Alanine Transaminase/metabolism , Animals , Biomarkers/metabolism , Blood Glucose/metabolism , Creatine Kinase/metabolism , Creatinine/metabolism , Female , HMGB1 Protein/metabolism , Hyperglycemia/physiopathology , Inflammation/physiopathology , Inflammation/prevention & control , Interleukin-6/metabolism , Male , Random Allocation , Rats, Sprague-Dawley , Triggering Receptor Expressed on Myeloid Cells-1/metabolism , Tumor Necrosis Factor-alpha/metabolism
5.
Mol Med Rep ; 17(1): 683-693, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29115473

ABSTRACT

A novel diagnostic scheme that includes pancreatic ß­cell dysfunction analysis for the diagnosis of traumatic multiple organ dysfunction syndrome (MODS) was investigated to assist in the early diagnosis and detection of MODS. Early intervention and treatment of MODS has been associated with a reduced mortality rate. A total of 2,876 trauma patients (including patients post­major surgery) were admitted to the intensive care unit of the authors' hospital between December 2010 and December 2015 and enrolled in the present study. There were 205 cases where the patient succumbed to their injuries. In addition to the conventional diagnostic scheme for traumatic MODS, indexes of pancreatic ß­cell dysfunction [fasting blood­glucose (FBG), homeostatic model assessment­ß and (blood insulin concentration 30 min following glucose loading­fasting insulin concentration)/(blood glucose concentration 30 min following glucose loading­FBG concentration)] were included to establish an improved diagnostic scheme for traumatic MODS. The novel scheme was subsequently used in clinical practice alongside the conventional scheme and its effect was evaluated. The novel scheme had a significantly higher positive number of MODS diagnoses for all trauma patients compared with the conventional scheme (12.48 vs. 8.87%; P<0.01). No significant difference was identified in the final percentage of positive of MODS diagnoses for trauma­associated mortality patients between the novel (88.30%) and the conventional scheme (86.34%). The novel scheme had a significantly higher positive number of MODS diagnoses for trauma­associated mortality patients 3 days prior to patients succumbing to MODS compared with the conventional scheme (80.98 vs. 64.39%; P<0.01). The consensus of the MODS diagnosis of all trauma patients between the novel scheme and the conventional scheme was 100%; however, out of the patients diagnosed as positive by novel scheme 71.03% were positive by the conventional scheme. The consensus between the final MODS diagnosis and the MODS diagnosis 3 days prior to patients succumbing to their injuries between the novel scheme and the conventional scheme was 100%; however, out of the patients diagnosed as positive by novel scheme 97.79 were positive by the conventional scheme of the 205 patients who succumbed to MODS and out of the patients diagnosed as positive for MODS by novel scheme 3 days prior to succumbing, 79.52% were positive by the conventional scheme. The results of the present study demonstrated that the novel diagnostic scheme using the relevant indexes of pancreatic ß­cell dysfunction for diagnosis of traumatic MODS, was able to diagnose MODS early without excessively extending the diagnostic scope. Its clinical application should be promoted.


Subject(s)
Insulin-Secreting Cells/pathology , Multiple Organ Failure/diagnosis , Postoperative Complications/diagnosis , Wounds and Injuries/diagnosis , Adult , Aged , Blood Glucose , Female , Humans , Insulin/blood , Intensive Care Units , Male , Middle Aged , Multiple Organ Failure/blood , Multiple Organ Failure/complications , Multiple Organ Failure/physiopathology , Postoperative Complications/blood , Postoperative Complications/pathology , Wounds and Injuries/blood , Wounds and Injuries/complications , Wounds and Injuries/pathology
6.
Am J Emerg Med ; 34(11): 2154-2158, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27567422

ABSTRACT

BACKGROUND: Inflammation response and oxidative stress promote the occurrence and development of multiple-organ dysfunction syndrome (MODS). METHODS: Eighty MODS rats with third-degree burns were divided randomly into 4 groups: insulin, ethyl pyruvate (EP), insulin combined with EP, and control. Blood levels of glucose, alanine aminotransferase (ALT), creatine (CRE), creatine kinase (CK), tumor necrosis factor α (TNF-α), high-mobility group box 1 (HMGB-1), malondialdehyde (MDA), and total antioxidant capacity (TAC) before as well as 1, 3, 5, and 7 days after burns were measured. RESULTS: Blood levels of ALT, CRE, CK, TNF-α, HMGB-1, and MDA in INS, EP, and INS+EP groups at different time points were significantly lower, and TAC was significantly higher than that in the control group (C) (P<.01). These parameters in the INS+EP group were significantly lower, and TAC was significantly higher than that in INS and EP groups (P<.01). Blood levels of TNF-α, HMGB-1, and TAC in the INS group at different time points after burns were significantly lower, and MDA was significantly higher than that in the EP group (P<.01). CONCLUSIONS: Insulin combined with EP can effectively reduce the inflammatory response, oxidative stress, and main organ dysfunctions in MODS rats after severe burns. The therapeutic effect of insulin combined with EP is superior to single-agent treatment. The insulin anti-inflammatory effect is better than that of pyruvic acid ethyl ester, and the ethyl pyruvate antioxidation effect is better than that of insulin. The insulin can treat inflammation, whereas EP can reduce oxidative stress in MODS rats.


Subject(s)
Burns/blood , Hypoglycemic Agents/therapeutic use , Inflammation/drug therapy , Insulin/therapeutic use , Multiple Organ Failure/blood , Oxidative Stress/drug effects , Pyruvates/therapeutic use , Alanine Transaminase/blood , Animals , Antioxidants/metabolism , Blood Glucose , Burns/complications , Creatine/blood , Creatine Kinase/blood , Drug Therapy, Combination , HMGB1 Protein/blood , Inflammation/blood , Inflammation/etiology , Malondialdehyde/blood , Multiple Organ Failure/etiology , Rats , Rats, Sprague-Dawley , Time Factors , Tumor Necrosis Factor-alpha/blood
7.
Burns ; 38(6): 846-54, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22341647

ABSTRACT

Intestinal barrier damage after scald and burns, other trauma or major operations result in severe intestinal infections that cause serious consequences. Therefore, it is important to develop methods to protect intestinal barrier after severe burns. This study used rats that had full-thickness burn of approximately 30% of the total body surface area to investigate the effect and mechanism of glucose-insulin-potassium (GIK) and provide experimental evidence for application of GIK in protecting the intestine after burns or other trauma and major surgeries. The results show that the degree of intestinal damage and plasma diamine oxidase (DAO) levels in GIK (the concentrations of glucose, insulin, sodium chloride and potassium chloride were 100 g l(-1), 70 U l(-1), 9 g l(-1) and 5 g l(-1), respectively) and insulin (30 IU l(-1)) treatment groups were significantly lower than that in control group; the status of anti-inflammatory and pro-inflammatory cytokines and the ratio between them in GIK and insulin groups also significantly improved compared to those in control group; intestinal tumour necrosis factor-alpha (TNFα), nuclear factor-kappaB (NF-κB) and interleukin-10 (IL-10) messenger RNA (mRNA) expression and IL10/TNFα in GIK and insulin groups 2 days after the injury were also improved significantly compared to those in control group. All the indices including body weight detected in GIK group were improved to those in insulin group. Taken together, these results show that GIK and insulin show protective effect on intestine after severe burn, which may relate to controlling hyperglycaemia and regulating intestinal expression of NFκB and pro-inflammatory and anti-inflammatory cytokine genes by GIK and insulin; the protective effect of GIK on intestinal tissue after severe burn is superior to that of using insulin alone, which may attribute to improving the nutritional status by glucose supplement and the relatively higher dose of insulin in the GIK group.


Subject(s)
Burns/complications , Intestinal Diseases/prevention & control , Intestinal Mucosa/drug effects , Protective Agents/therapeutic use , Amine Oxidase (Copper-Containing)/blood , Analysis of Variance , Animals , Biomarkers/metabolism , Body Weight/physiology , Burns/metabolism , Cytokines/metabolism , Disease Models, Animal , Female , Glucose/pharmacology , Glucose/therapeutic use , Insulin/pharmacology , Insulin/therapeutic use , Intestinal Diseases/metabolism , Intestinal Diseases/pathology , Intestinal Mucosa/metabolism , Male , Potassium/pharmacology , Potassium/therapeutic use , RNA, Messenger/metabolism , Random Allocation , Rats , Rats, Sprague-Dawley
8.
Zhonghua Shao Shang Za Zhi ; 21(6): 422-5, 2005 Dec.
Article in Chinese | MEDLINE | ID: mdl-16480620

ABSTRACT

OBJECTIVE: To evaluate the influence of glucose-insulin-potassium treatment (GIK) on the levels of inflammatory cytokines in the scalded rats with MODS. METHODS: One hundred and twenty Sprague Dawley rats were inflicted with 30% TBSA full-thickness scalding, and MODS model was reproduced with intraperitoneal injection of endotoxin following burn injury. Then the rats were randomly divided into GIK, glucose (G) and control (C) groups, with 40 rats in each group. The serum contents of glucose, lactate acid, TNF-alpha, NO and IL-6 of the rats in the three groups were determined during 1 to 7 PSD, and the mortality rate within 7 PSD was observed. RESULTS: The serum contents of glucose, lactate acid, TNF-alpha, NO and IL-6 of the rats in the GIK group were obviously lower than those in the other two groups during 1 to 7 PSD (P < 0.01), and reached the lowest level at 6 to 7 PSD (TNF-alpha: 2.37 +/- 0.54 microg/L; IL-6: 0.28 +/- 0.17 microg/L; NO: 29 +/- 9 micromol/L). The content of glucose and lactate acid in G group were obviously higher than those in control group (P < 0.01), but the contents of TNF-alpha, IL-6 and NO content were similar between these two groups (P > 0.05). The mortality in GIK group within 7 PSD was 20.0%, which was evidently lower than that in G (37.5%) and C (47.5%) groups (P < 0.05), while that between G and C groups was similar (P > 0.05). CONCLUSION: The administration of GIK might ameliorate sepsis by reducing the levels of inflammatory cytokine after burns and endotoxin challenge.


Subject(s)
Burns/metabolism , Cytokines/metabolism , Multiple Organ Failure/metabolism , Animals , Blood Glucose/metabolism , Burns/complications , Burns/diagnosis , Disease Models, Animal , Glucose/therapeutic use , Insulin/therapeutic use , Lactic Acid/blood , Multiple Organ Failure/diagnosis , Multiple Organ Failure/etiology , Potassium/therapeutic use , Prognosis , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...